Pfizer, BioNTech Say COVID-19 Vaccine “Can Stand Warmer Temperatures” — Report

Pfizer and BioNTech reportedly said that their COVID-19 vaccine “can stand warmer temperatures”.

Pfizer and BioNTech on Friday said that their COVID-19 vaccine “can stand warmer temperatures”, according to a report.

Pfizer BioNTech Warmer Temperatures
Photo source: Manila Bulletin

In a report on GMA News Online, Pfizer and BioNTech said that tests had shown that their COVID-19 vaccine can stand warmer temperatures than initially thought, potentially simplifying the vaccine’s complex cold-chain logistics.

Pfizer and BioNTech said that they had asked the United States Food and Drug Administration (US FDA) to allow for the COVID-19 vaccine to be stored for up to two weeks at -25°C to -15°C (-13°F to +5°F) — temperatures commonly found in pharmaceutical freezers and refrigerators.

READ ALSO: Johnson & Johnson Submits Emergency Use Listing To WHO For COVID-19 Vaccine

Under the existing guidelines, however, the Pfizer-BioNTech COVID-19 vaccine needed to be stored at -80°C to -60°C until 5 days before use, a delicate process that required “special ultra-cold containers” for shipping and dry ice for storage.

As per the report, Pfizer CEO Albert Bourla said in a statement that if approved, the said new storage option would offer vaccination centers and pharmacies greater flexibility in how they managed their vaccine supply.

In a separate report on Inquirer, Pfizer and BioNTech said that they had submitted new data to the US FDA showing the stability of their COVID-19 vaccine at temperatures commonly found in refrigerators and pharmaceutical freezers.

For more news and updates, you may feel free to visit this site more often. You may also visit via our official Facebook page and YouTube channel.

Leave a Comment